Summary
President Donald Trump announced plans for a major announcement related to Autism Spectrum Disorder (ASD) policies in the U.S. Reports suggest the announcement may involve claims about the effects of acetaminophen use during pregnancy and potential treatments like leucovorin. The CDC's data on autism prevalence differs from Trump's remarks.
Key Facts
- President Trump announced plans for a significant policy announcement on autism.
- Reports indicate the announcement may link acetaminophen use during pregnancy to autism.
- Leucovorin is mentioned as a potential treatment in the new plans.
- The CDC data states that 1 in 31 8-year-olds are diagnosed with autism.
- Trump referenced higher figures in his remarks about autism prevalence.
- There are differences between Trump's figures and established CDC data.
- Top health officials, such as the FDA and NIH directors, are involved.
- Trump's remarks included controversial views about vaccines and autism.
